Pacher P, Batkai S, Kunos G (2004) Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J Physiol
Padley JR, Li Q, Pilowsky PM, Goodchild AK (2003) Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats. Br J Pharmacol 140: 384-394
Page DT (2003) A function for Egf receptor signaling in expanding the developing brain in Drosophila. Curr Biol 13: 474-482
Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grubler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B, Stalla GK (2001) Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab 86: 2687-2696
Palade P (1987) Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. III. Block of Ca2+-induced Ca2+ release by organic polyamines. J Biol Chem 262: 6149-6154
Palade P, Dettbarn C, Alderson B, Volpe P (1989) Pharmacologic differentiation between inositol-1,4,5-trisphosphate-induced Ca2+ release and Ca2+- or caffeine-induced Ca2+ release from intracellular membrane systems. Mol Pharmacol 36: 673-680
Palade P, Dettbarn C, Volpe P, Alderson B, Otero AS (1989) Direct inhibition of inositol-1,4,5-trisphosphate-induced Ca2+ release from brain microsomes by K+ channel blockers. Mol Pharmacol 36: 664-672
Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Maione S (2001) Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology 40: 319-326
Palkovits M (2000) [The brain and the pain: neurotransmitters and neuronal pathways of pain perception and response]. Orv Hetil 141: 2231-2239
Palmer SL, Khanolkar AD, Makriyannis A (2000) Natural and synthetic endocannabinoids and their structure-activity relationships. Curr Pharm Des 6: 1381-1397
Palmer SL, Thakur GA, Makriyannis A (2002) Cannabinergic ligands. Chem Phys Lipids 121: 3-19
Palnitkar SS, Bin B, Jimenez LS, Morimoto H, Williams PG, Paul-Pletzer K, Parness J (1999) [3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J Med Chem 42: 1872-1880
Pan X, Ikeda SR, Lewis DL (1996) Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. Mol Pharmacol 49: 707-714
Pan X, Ikeda SR, Lewis DL (1998) SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54: 1064-1072
Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531
Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG (2002) A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res 130: 171-179
Papahatjis DP, Kourouli T, Abadji V, Goutopoulos A, Makriyannis A (1998) Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols. J Med Chem 41: 1195-1200
Papahatjis DP, Nikas SP, Kourouli T, Chari R, Xu W, Pertwee RG, Makriyannis A (2003) Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'. J Med Chem 46: 3221-3229
Papanastassiou AM, Fields HL, Meng ID (2004) Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons. Pain 107: 267-275
Pape JR, Skynner MJ, Sim JA, Herbison AE (2001) Profiling gamma-aminobutyric acid (GABA(A)) receptor subunit mRNA expression in postnatal gonadotropin-releasing hormone (GnRH) neurons of the male mouse with single cell RT-PCR. Neuroendocrinology 74: 300-308
Paranavitane V, Coadwell WJ, Eguinoa A, Hawkins PT, Stephens L (2003) LL5beta is a phosphatidylinositol (3,4,5)-trisphosphate sensor that can bind the cytoskeletal adaptor, gamma-filamin. J Biol Chem 278: 1328-1335
Parentin F (2003) Granulomatous anterior uveitis associated with bimatoprost: a case report. Ocul Immunol Inflamm 11: 67-71
Paria BC, Das SK, Dey SK (1995) The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci U S A 92: 9460-9464
Paria BC, Deutsch DD, Dey SK (1996) The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Reprod Dev 45: 183-192
Paria BC, Dey SK (2000) Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 108: 211-220
Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK (1998) Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod 58: 1490-1495
Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, Bonner TI, Zimmer A, Dey SK (2001) Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 276: 20523-20528
Paria BC, Wang H, Dey SK (2002) Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem Phys Lipids 121: 201-210
Paria BC, Zhao X, Wang J, Das SK, Dey SK (1999) Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol Reprod 60: 1151-1157
Parinandi NL, Schmid HH (1988) Effects of long-chain N-acylethanolamines on lipid peroxidation in cardiac mitochondria. FEBS Lett 237: 49-52
Park B, Gibbons HM, Mitchell MD, Glass M (2003) Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 24: 990-995
Park B, Gibbons HM, Mitchell MD, Glass M (2003) Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta (vol 24, pg 990, 2003). Placenta 24: 990-995
Park B, McPartland JM, Glass M (2004) Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 70: 189-197
Park K, Brown PD (1994) Intracellular pH modulates ion channel activity in lacrimal gland acinar cells. Jpn J Physiol 44 Suppl 2: S255-259
Park K, Brown PD (1995) Intracellular pH modulates the activity of chloride channels in isolated lacrimal gland acinar cells. Am J Physiol 268: C647-650
Park KP, Beck JS, Douglas IJ, Brown PD (1994) Ca(2+)-activated K+ channels are involved in regulatory volume decrease in acinar cells isolated from the rat lacrimal gland. J Membr Biol 141: 193-201
Parker LA, Kwiatkowska M, Burton P, Mechoulam R (2004) Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) 171: 156-161
Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22: 9771-9775
Parod RJ, Leslie BA, Putney JW, Jr. (1980) Muscarinic and alpha-adrenergic stimulation of Na and Ca uptake by dispersed lacrimal cells. Am J Physiol 239: G99-105
Parod RJ, Putney JW, Jr. (1978) The role of calcium in the receptor mediated control of potassium permeability in the rat lacrimal gland. J Physiol 281: 371-381
Parod RJ, Putney JW, Jr. (1979) Stimulation of 45Ca efflux from rat lacrimal gland slices by carbachol and epinephrine. Life Sci 25: 2211-2215
Parod RJ, Putney JW, Jr. (1980) Stimulus-permeability coupling in rat lacrimal gland. Am J Physiol 239: G106-113
Parolaro D, Massi P, Rubino T, Monti E (2002) Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids 66: 319-332
Parolaro D, Rubino T (2002) Is cannabinoid transmission involved in rewarding properties of drugs of abuse? Br J Pharmacol 136: 1083-1084
Parrott RF, Vellucci SV (2000) Behaviour of pigs given corticotrophin-releasing hormone in combination with flumazenil or diazepam. Pharmacol Biochem Behav 67: 465-471
Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191: 573-578
Partosoedarso ER, Abrahams TP, Scullion RT, Moerschbaecher JM, Hornby PJ (2003) Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J Physiol 550: 149-158
Pascall JC, Brown KD (2004) Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem Biophys Res Commun 317: 244-252
Pascall JC, Luck JE, Brown KD (2002) Expression in mammalian cell cultures reveals interdependent, but distinct, functions for Star and Rhomboid proteins in the processing of the Drosophila transforming-growth-factor-alpha homologue Spitz. Biochem J 363: 347-352
Passchier J, Gee A, Willemsen A, Vaalburg W, van Waarde A (2002) Measuring drug-related receptor occupancy with positron emission tomography. Methods 27: 278-286
Passetti F, Dalley JW, Robbins TW (2003) Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl) 165: 136-145
Passetti F, Levita L, Robbins TW (2003) Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav Brain Res 138: 59-69
Pate DW, Jarvinen K, Urtti A, Jarho P, Fich M, Mahadevan V, Jarvinen T (1996) Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sci 58: 1849-1860
Pate DW, Jarvinen K, Urtti A, Jarho P, Jarvinen T (1995) Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr Eye Res 14: 791-797
Pate DW, Jarvinen K, Urtti A, Jarho P, Mahadevan V, Jarvinen T (1997) Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. Pharm Res 14: 1738-1743
Pate DW, Jarvinen K, Urtti A, Mahadevan V, Jarvinen T (1998) Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. Life Sci 63: 2181-2188
Patel HJ, Birrell MA, Crispino N, Hele DJ, Venkatesan P, Barnes PJ, Yacoub MH, Belvisi MG (2003) Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140: 261-268
Patel MK, Pinnock RD, Lee K (2001) Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord. Brain Res 920: 19-26
Patel NA, Moldow RL, Patel JA, Wu G, Chang SL (1998) Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. Brain Res 797: 225-233
Patel S, Gerrits R, Muthian S, Greene AS, Hillard CJ (2002) The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Neurosci Lett 335: 95-98
Patel S, Joseph SK, Thomas AP (1999) Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25: 247-264
Patel S, Morris SA, Adkins CE, O'Beirne G, Taylor CW (1997) Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci U S A 94: 11627-11632
Patel S, Rademacher DJ, Hillard CJ (2003) Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306: 880-888
Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ (2003) The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol 139: 1005-1013
Paton GS, Pertwee RG, Davies SN (1998) Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice. Neuropharmacology 37: 1123-1130
Patricelli MP, Cravatt BF (1999) Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry 38: 14125-14130
Patricelli MP, Cravatt BF (2000) Clarifying the catalytic roles of conserved residues in the amidase signature family. J Biol Chem 275: 19177-19184
Patricelli MP, Cravatt BF (2001) Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Biochemistry 40: 6107-6115
Patricelli MP, Cravatt BF (2001) Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides. Vitam Horm 62: 95-131
Patricelli MP, Lashuel HA, Giang DK, Kelly JW, Cravatt BF (1998) Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry 37: 15177-15187
Patricelli MP, Lovato MA, Cravatt BF (1999) Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Biochemistry 38: 9804-9812
Patricelli MP, Patterson JE, Boger DL, Cravatt BF (1998) An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase. Bioorg Med Chem Lett 8: 613-618
Patrignani P (2001) Oxidized lipids. Ital Heart J 2: 873-877
Patrini G, Sacerdote P, Fuzio D, Manfredi B, Parolaro D (1997) Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound. J Neuroimmunol 80: 143-148
Patterson RL, van Rossum DB, Gill DL (1999) Store-operated Ca2+ entry: evidence for a secretion-like coupling model. Cell 98: 487-499
Paul-Pletzer K, Palnitkar SS, Jimenez LS, Morimoto H, Parness J (2001) The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry 40: 531-542
Pazirandeh M, Chirala SS, Wakil SJ (1991) Site-directed mutagenesis studies on the recombinant thioesterase domain of chicken fatty acid synthase expressed in Escherichia coli. J Biol Chem 266: 20946-20952
Pearlman RJ, Aubrey KR, Vandenberg RJ (2003) Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. J Neurochem 84: 592-601
Pelham HR (1999) SNAREs and the secretory pathway-lessons from yeast. Exp Cell Res 247: 1-8
Pelham HR (2001) SNAREs and the specificity of membrane fusion. Trends Cell Biol 11: 99-101
Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL (2003) 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34: 97-108
Percipalle P, Butler PJ, Finch JT, Jans DA, Rhodes D (1999) Nuclear localization signal recognition causes release of importin-alpha from aggregates in the cytosol. J Mol Biol 292: 263-273
Perez PJ, Ramos-Franco J, Fill M, Mignery GA (1997) Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem 272: 23961-23969
Perio A, Barnouin MC, Poncelet M, Soubrie P (2001) Activity of SH141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behav Pharmacol 12: 641-645
Perio A, Rinaldi-Carmona M, Maruani J, Barth F, Le Fur G, Soubrie P (1996) Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav Pharmacol 7: 65-71
Perrier JF, Alaburda A, Hounsgaard J (2003) 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle. J Physiol 548: 485-492
Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A (1995) AM630, a competitive cannabinoid receptor antagonist. Life Sci 56: 1949-1955
Pertwee R, Griffin G, Hanus L, Mechoulam R (1994) Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia. Eur J Pharmacol 259: 115-120
Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180
Pertwee RG (1999) Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed 6 Suppl 3: 12-15
Pertwee RG (1999) Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci 65: 597-605
Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6: 635-664
Pertwee RG (2000) Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Investig Drugs 9: 1553-1571
Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611
Pertwee RG (2001) Cannabinoids and the gastrointestinal tract. Gut 48: 859-867
Pertwee RG (2002) Cannabinoids and multiple sclerosis. Pharmacol Ther 95: 165-174
Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118: 2053-2058
Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol 272: 73-78
Pertwee RG, Fernando SR, Griffin G, Ryan W, Razdan RK, Compton DR, Martin BR (1996) Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. Eur J Pharmacol 315: 195-201
Pertwee RG, Fernando SR, Nash JE, Coutts AA (1996) Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol 118: 2199-2205
Pertwee RG, Gibson TM, Stevenson LA, Ross RA, Banner WK, Saha B, Razdan RK, Martin BR (2000) O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties. Br J Pharmacol 129: 1577-1584
Pertwee RG, Griffin G, Lainton JA, Huffman JW (1995) Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur J Pharmacol 284: 241-247
Pertwee RG, Joe-Adigwe G, Hawksworth GM (1996) Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens. Eur J Pharmacol 296: 169-172
Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66: 101-121
Pertwee RG, Stevenson LA, Griffin G (1993) Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br J Pharmacol 110: 1483-1490
Pessah IN, Francini AO, Scales DJ, Waterhouse AL, Casida JE (1986) Calcium-ryanodine receptor complex. Solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles. J Biol Chem 261: 8643-8648
Pestonjamasp VK, Burstein SH (1998) Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta 1394: 249-260
Pesty A, Avazeri N, Lefevre B (1998) Nuclear calcium release by InsP3-receptor channels plays a role in meiosis reinitiation in the mouse oocyte. Cell Calcium 24: 239-251
Petersen G, Chapman KD, Hansen HS (2000) A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to n-acylethanolamine formation in vitro. J Lipid Res 41: 1532-1538
Petersen G, Hansen HS (1999) N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate. FEBS Lett 455: 41-44
Petersen OH (1986) Calcium-activated potassium channels and fluid secretion by exocrine glands. Am J Physiol 251: G1-13
Petersen OH, Cancela JM (1999) New Ca2+-releasing messengers: are they important in the nervous system? Trends Neurosci 22: 488-495
Petitet F, Jeantaud B, Bertrand P, Imperato A (1999) Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol 374: 417-421
Petitet F, Jeantaud B, Capet M, Doble A (1997) Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study. Biochem Pharmacol 54: 1267-1270
Petitou M, Herault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM (1999) Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 398: 417-422
Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GA (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 51: 391-402
Phillips T, Makoff A, Murrison E, Mimmack M, Waldvogel H, Faull R, Rees S, Emson P (1998) Immunohistochemical localisation of mGluR7 protein in the rodent and human cerebellar cortex using subtype specific antibodies. Brain Res Mol Brain Res 57: 132-141
Pholpramool C, Korppaibool S (1977) Ionic dependence of the resting membrane potential of rabbit lacrimal gland in vitro. Biochim Biophys Acta 468: 353-363
Pholpramool C, Tangkrisanavinont V (1976) A calcium ionophore-induced secretion in rabbit lacrimal gland in vivo. Life Sci 19: 381-388
Picone RP, Fournier DJ, Makriyannis A (2002) Ligand based structural studies of the CB1 cannabinoid receptor. J Pept Res 60: 348-356
Pietras TA, Rowland NE (2002) Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats. European Journal of Pharmacology 442: 237-239
Pignatelli M, Grammatikopoulos G, Giuliano A, Ruocco L, Scamardella M, Sadile AG (2001) Prenatal elevation of endocannabinoids reduces hyperactivity in the Naples High Excitability rat. Society for Neuroscience Abstracts 27
Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW (2001) Inhibition of Na(+)/H(+) exchange by SM-20220 attenuates free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Brain Res 913: 156-158
Pinto JC, Potie F, Rice KC, Boring D, Johnson MR, Evans DM, Wilken GH, Cantrell CH, Howlett AC (1994) Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol Pharmacol 46: 516-522
Pinto L, Capasso R, Di Carlo G, Izzo AA (2002) Endocannabinoids and the gut. Prostaglandins Leukot Essent Fatty Acids 66: 333-341
Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR, Mascolo N, Di Marzo V, Capasso F (2002) Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123: 227-234
Piomelli D (2000) Biochemistry and pharmacology of the endocannabinoid system. Abstracts of Papers American Chemical Society 219
Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884
Piomelli D (2004) THC: moderation during implantation. Nat Med 10: 19-20
Piomelli D, Beltramo M, Giuffrida A, Stella N (1998) Endogenous cannabinoid signaling. Neurobiol Dis 5: 462-473
Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie XQ, Makriyannis A (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci U S A 96: 5802-5807
Piomelli D, Freund TF, Nicoll R, Regehr W (2002) The Endogenous Cannabinoids: Retrograde Modulators of Synaptic Activity. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21: 218-224
Pirtle RM, Yoder DW, Huynh TT, Nampaisansuk M, Pirtle IL, Chapman KD (1999) Characterization of a palmitoyl-acyl carrier protein thioesterase (FatB1) in cotton. Plant and Cell Physiology 40: 155-163
Pistis M, Muntoni AL, Pillolla G, Gessa GL (2002) Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur J Neurosci 15: 1795-1802
Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL (2004) Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46: 115-125
Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP (1997) Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121: 1509-1511
Plant LD, Kemp PJ, Peers C, Henderson Z, Pearson HA (2002) Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke 33: 2324-2328
Plhackova K, Becka S, Skrob F, Kyslik P (2003) Isolation and characterization of a new strain of Achromobacter sp. with beta-lactam antibiotic acylase activity. Appl Microbiol Biotechnol 62: 507-516
Poitry S, Poitry-Yamate C, Ueberfeld J, MacLeish PR, Tsacopoulos M (2000) Mechanisms of glutamate metabolic signaling in retinal glial (Muller) cells. J Neurosci 20: 1809-1821
Poling JS, Rogawski MA, Salem N, Jr., Vicini S (1996) Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels. Neuropharmacology 35: 983-991
Ponce G, Hoenicka J, Rubio G, Ampuero I, Jimenez-Arriero MA, Rodriguez-Jimenez R, Palomo T, Ramos JA (2003) Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry 8: 466-467
Poncelet M, Barnouin MC, Breliere JC, Le Fur G, Soubrie P (1999) Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils. Psychopharmacology (Berl) 144: 144-150
Poncelet M, Maruani J, Calassi R, Soubrie P (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343: 216-218
Ponting CP (2000) Novel repeats in ryanodine and IP3 receptors and protein O-mannosyltransferases. Trends Biochem Sci 25: 48-50
Pop E (1999) Cannabinoids, endogenous ligands and synthetic analogs. Curr Opin Chem Biol 3: 418-425
Porcella A, Casellas P, Gessa GL, Pani L (1998) Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res 58: 240-245
Porcella A, Marchese G, Casu MA, Rocchitta A, Lai ML, Gessa GL, Pani L (2002) Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. Eur J Endocrinol 147: 255-261
Porcella A, Marchese G, Casu MA, Rocchitta A, Lai ML, Gessa GL, Pani L (2002) Evidence for Functional Cb1 Cannabinoid Receptor Expressed in the Rat Thyroid Gland. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Porcella A, Maxia C, Gessa GL, Pani L (2000) The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci 12: 1123-1127
Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M (2003) Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. Faseb J 17: 1771-1773
Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90: 45-60
Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301: 1020-1024
Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G, Casellas P (1999) SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J Pharmacol Exp Ther 288: 582-589
Poulet JF, Hedwig B (2001) Tympanic membrane oscillations and auditory receptor activity in the stridulating cricket Gryllus bimaculatus. J Exp Biol 204: 1281-1293
Pow DV, Barnett NL (2000) Developmental expression of excitatory amino acid transporter 5: a photoreceptor and bipolar cell glutamate transporter in rat retina. Neurosci Lett 280: 21-24
Pozo D (2003) VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools. Trends Mol Med 9: 211-217
Pozzi O, Misiano P, Clark GD, Visentin L (2003) Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A. Pharmacology 69: 158-163
Prather PL, Martin NA, Breivogel CS, Childers SR (2000) Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol 57: 1000-1010
Pratt PF, Hillard CJ, Edgemond WS, Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 274: H375-381
Preece M, Mukherjee B, Huang CL, Hall LD, Leslie RA, James MF (2001) Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat. Brain Res 916: 107-114
Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408: 985-990
Preston Z, Lee K, Widdowson L, Freeman TC, Dixon AK, Richardson PJ (2000) Adenosine receptor expression and function in rat striatal cholinergic interneurons. Br J Pharmacol 130: 886-890
Preuss UW, Koller G, Zill P, Bondy B, Soyka M (2003) Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur Arch Psychiatry Clin Neurosci 253: 275-280
Prevot V, Rialas CM, Croix D, Salzet M, Dupouy JP, Poulain P, Beauvillain JC, Stefano GB (1998) Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res 790: 236-244
Price KL, Lummis SC (2004) The role of tyrosine residues in the extracellular domain of the 5-HT3 receptor. J Biol Chem
Price TJ, Helesic G, Parghi D, Hargreaves KM, Flores CM (2003) The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience 120: 155-162
Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM (2004) Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141: 1118-1130
Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC (1995) Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol Pharmacol 48: 288-292
Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10: 227-230
Pritchard NR, Smith KG (2003) B cell inhibitory receptors and autoimmunity. Immunology 108: 263-273
Proescholdt MG, Quigley L, Martin R, Herkenham M (2002) Immunization with a cannabinoid receptor type 1 peptide results in experimental allergic meningocerebellitis in the Lewis rat: a model for cell-mediated autoimmune neuropathology. J Neurosci Res 70: 150-160
Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, Cuzner ML, Baker D (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126: 2191-2202
Pryor SR (2000) Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. Med Hypotheses 55: 494-501
Puffenbarger RA, Boothe AC, Cabral GA (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29: 58-69
Puffenbarger RA, Kapulina O, Howell JM, Deutsch DG (2001) Characterization of the 5'-sequence of the mouse fatty acid amide hydrolase. Neurosci Lett 314: 21-24
Puig-Domingo M, Guerrero JM, Reiter RJ, Peinado MA, Sabry I, Viader M, Webb SM (1988) Identification of immunoreactive somatostatin in the rat harderian gland: regulation of its content by growth hormone, beta-adrenergic agonists and calcium channel blockers. Peptides 9: 571-574
Purvis D, Leonardova O, Farmakovsky D, Cherkasov V (2003) An ultrasensitive and stable potentiometric immunosensor. Biosens Bioelectron 18: 1385-1390
Pushkarev V, Tronko N, Kostyuchenko N, Kovalenko A, Mikosha A (2001) Modulation by N-stearoylethanolamine of K+ and mitotane effects on steroid hormones labeling in human adrenocortical tissue. Biomedical Research (Tokyo) 22: 191-195
Putney JW, Jr. (1978) Stimulus-permeability coupling: role of calcium in the receptor regulation of membrane permeability. Pharmacol Rev 30: 209-245
Putney JW, Jr., Bird GS (1994) The inositol phosphate-calcium signalling system in lacrimal gland cells. Adv Exp Med Biol 350: 115-119
Putney JW, Jr., Huang Y, Bird GS (1998) Calcium signalling in lacrimal acinar cells. Adv Exp Med Biol 438: 123-128
Putney JW, Jr., Parod RJ, Marier SH (1977) Control by calcium of protein discharge and membrane permeability to potassium in the rat lacrimal gland. Life Sci 20: 1905-1911
Putney JW, Jr., VandeWalle CM, Leslie BA (1978) Stimulus-secretion coupling in the rat lacrimal gland. Am J Physiol 235: C188-198